$RTX

RTX and Northrop Grumman raise 2026 profit outlooks on military rearmament demand

RTX (RTX) and Northrop Grumman (NOC) raised 2026 profit forecasts due to strong military demand. RTX expects EPS of $7.65-$7.75 and revenue of $97B-$97.5B. NOC projects EPS of $29.35-$29.75 and revenue of $43.75B-$44.25B. Both cite robust backlogs and defense contracts. Shares reacted mixedly, with RTX down 1% and NOC up 5%.

Original reporting
Published Oct 20, 2026, 5:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 5:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RTX and Northrop Grumman raise 2026 profit outlooks on military rearmament demand — source image
Decision brief

The 30-second read

$RTXBearishHigh
01

Why it matters

Guidance upgrades reflect strong order flow but also highlight reliance on future budget approvals.

02

Market read

Defense earnings outlooks are a key driver for sector momentum amid heightened rearmament spending.

03

What to watch

Potential delays in FY2027 defense budget approval could temper the upside.

Relevance 8/10Novelty 8/10Timing: today

Background

Both companies cited record backlogs and ongoing geopolitical conflicts driving demand.

Company-level read

Ticker impact

$RTXBearishHigh confidence
Context

RTX raised its 2026 EPS guidance to $7.65-$7.75 and revenue to $97B-$97.5B, the first disclosure of the updated outlook.

Expected impact

likely pressure as the market digests the guidance increase versus expectations

Evidence & confidence

The guidance raise is new information but the stock reacted negatively, suggesting investors remain cautious.

$NOCBullishHigh confidence
Context

Northrop Grumman lifted its 2026 EPS guidance to $29.35-$29.75, the first public update of its outlook.

Expected impact

likely upside as investors reward the stronger earnings outlook

Evidence & confidence

The fresh guidance and record backlog drive a positive price move.

Market effects

Higher guidance may lift the broader defense sector as rearmament demand accelerates.

U.S. defense stocks could outperform the S&P 500 in the near term.

Global investors tracking defense exposure may adjust allocations toward U.S. primes.

Counterpoint

The guidance lifts may already be priced in; a pullback in RTX could signal overoptimism.

Key entities

  • Raytheon

    RTX's weapons manufacturing unit with 14% YoY sales growth.

  • Aeronautics Systems

    Northrop's segment driving F‑35 and bomber sales.

Related articles

$NOCHighAI 8/10

Northrop Grumman (NOC) Q3 2026 Earnings Call Transcript

Northrop Grumman (NOC) reported Q3 2026 earnings with a 1.5x book-to-bill ratio, a record $110B backlog, and 12%+ operating margins. The company raised 2026 guidance and expects growth acceleration in 2027, driven by programs like Sentinel, B-21, and space systems. New products and strategic wins support long-term expansion, with international sales targeted to double by 2031.

$NOCMedAI 8/10

Northrop Grumman Corporation Q3 2026 Earnings Call Summary

Northrop Grumman reported Q3 2026 earnings, highlighting a record $110B backlog and 14% sales growth in Aeronautics. The company raised EPS guidance and expects 5-7% sales growth in 2027, with margin expansion. Capital expenditures are projected at $2.1B for 2027, and international sales are targeted to double by 2031. Management is exploring strategic options for its quantum and microelectronics business.

$RTXHighAI 8/10

RTX Corporation Q3 2026 Earnings Call Summary

RTX Corporation reported Q3 2026 earnings with double-digit organic growth across commercial, aftermarket, and defense segments. Raytheon saw 14% growth, driven by a 90% increase in munitions output. Collins Aerospace is reducing costs to expand margins. RTX raised its full-year 2026 outlook, citing strong defense performance and higher GTF aftermarket volumes. Management expects $70 billion in framework agreements to drive revenue for the next decade.

$RTXHighAI 8/10

RTX Stocks Rise as Earnings Gain Includes a 25-Cent Recovery

RTX stock rose 0.53% in premarket trading after raising its full-year outlook. The company reported adjusted earnings of $2.26 per share, including a $0.25 cost-recovery benefit, and sales of $24.965 billion. RTX's backlog reached $340 billion, and it raised its annual adjusted earnings forecast to $7.65–$7.75 per share.